Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2010
09/02/2010US20100221775 Increased production of secreted proteins by recombinant eukaryotic cells
09/02/2010US20100221773 Nucleic Acids Encoding a Functional Mammalin Purinoreceptor, P2X3, Methods of Production and Use Thereof
09/02/2010US20100221738 Method of diagnosis of a predisposition to develop thrombotic disease and its uses
09/02/2010US20100221733 Biomarker of allergic disease and use of the same
09/02/2010US20100221731 Methods for assessing MetAP2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer
09/02/2010US20100221730 Methods for assessing SPARC Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer
09/02/2010US20100221729 Methods for assessing Calpain 2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer
09/02/2010US20100221728 Method for quantifying initial concentration of nucleic acid from real-time nucleic acid amplification data
09/02/2010US20100221724 Patched polypeptides and uses related thereto
09/02/2010US20100221720 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
09/02/2010US20100221719 Probes for detecting protein nuclear transport and method for detecting and quantifying protein nuclear transport using the same
09/02/2010US20100221400 Engineering lipids in vegetative tissues of plants
09/02/2010US20100221385 Asparaginases
09/02/2010US20100221383 Gene encoding glycogen branching enzyme and use thereof
09/02/2010US20100221349 Nucleic acid constructs
09/02/2010US20100221346 Method For Transfecting Cells Using A Magnetic Field
09/02/2010US20100221318 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
09/02/2010US20100221317 Dynamin mediated diseases and associated methods and products
09/02/2010US20100221288 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/02/2010US20100221287 Streptococcus pneumoniae Polynucleotides and Sequences
09/02/2010US20100221283 Circovirus sequences associated with piglet weight loss disease (pwd)
09/02/2010US20100221282 Recombinant vaccine against west nile virus
09/02/2010US20100221279 Kennel cough vaccine
09/02/2010US20100221276 Circovirus sequences associated with piglet weight loss disease (pwd)
09/02/2010US20100221266 Methods to regulate mirna processing by targeting lin-28
09/02/2010US20100221264 Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
09/02/2010US20100221262 Anti-unc5b antibodies and methods of use
09/02/2010US20100221257 Binding members-513
09/02/2010US20100221256 Meningococcus adhesins nada, app and orf 40
09/02/2010US20100221255 Apelin peptides and methods of use
09/02/2010US20100221249 Wisp polypeptides and nucleic acids encoding same
09/02/2010US20100221248 Directed Engagement of Activating Fc Receptors
09/02/2010US20100221234 Bone delivery conjugates and method of using same to target proteins to bone
09/02/2010US20100221222 Interferons, uses and compositions related thereto
09/02/2010US20100221185 Vaccines and vaccine components for inhibition of microbial cells
09/02/2010US20100221179 IL-1 Binding Proteins
09/02/2010US20100221178 Method for Treating the TH2-Mediated Disease
09/02/2010DE112008001044T5 Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu ihrer Herstellung Plants having enhanced yield characteristics and methods for their preparation
09/02/2010DE102007008596B4 Biologisch wirksame Moleküle auf Grundlage von PNA und siRNA, Verfahren zu deren zellspezifischen Aktivierung sowie Applikationskit zur Verabreichung Biologically active molecules on the basis of PNA and siRNA, methods for their cell-specific activation and application kit for administering
09/02/2010DE10103509B4 Phosphoserinphospatase-Gen der coryneformen Bakterien Phosphoserinphospatase gene of coryneform bacteria
09/02/2010CA2772648A1 Antibodies specifically directed to the soluble form of ctla-4
09/02/2010CA2753845A1 Novel nuclear reprogramming substance
09/02/2010CA2753829A1 .beta.-glucan-deficient gene in barley, synthetic gene, and use of same
09/02/2010CA2753814A1 Novel selection vectors and methods of selecting eukaryotic host cells
09/02/2010CA2753813A1 Methods for selecting eukaryotic cells expressing a heterologous protein
09/02/2010CA2753796A1 Fusarium resistant cucumber plants
09/02/2010CA2753782A1 Signal sequence-independent pix phage display
09/02/2010CA2753759A1 Transgenic plants comprising constructs encoding phosphoenolpyruvate carboxykinase and/or pyruvate orthophosphate dikinase
09/02/2010CA2753584A1 Host cells and methods of use
09/02/2010CA2753562A1 Micrornas in never-smokers and related materials and methods
09/02/2010CA2753546A1 Methods for increasing starch content in plant cobs
09/02/2010CA2753491A1 Pesticidal proteins and methods for their use
09/02/2010CA2753481A1 Methods of detecting lung cancer
09/02/2010CA2753438A1 Antibodies containing therapeutic tpo/epo mimetic peptides
09/02/2010CA2753362A1 Reengineering mrna primary structure for enhanced protein production
09/02/2010CA2753271A1 Compositions and methods for performing hybridizations with separate denaturation of the sample and probe
09/02/2010CA2753103A1 Equol-producing bacterium and use thereof
09/02/2010CA2752818A1 Beta-glucosidase variant enzymes and related polynucleotides
09/02/2010CA2752681A1 Hyper ige animal model with enhanced immunoglobulin heavy chain class switching to c-epsilon
09/02/2010CA2752647A1 Designer ligands of tgf-beta superfamily
09/02/2010CA2752175A1 Alteration and modulation of protein activity by varying post-translational modification
09/02/2010CA2751730A1 Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris
09/02/2010CA2751323A1 Plants having enhanced yield-related traits and a method for making the same
09/02/2010CA2750920A1 Novel lignin-resistant cellulase enzymes
09/02/2010CA2744103A1 Methods for identifying immunobinders of cell-surface antigens
09/01/2010EP2224017A1 Method for amplifying target nucleic acid sequence and probe used for the same
09/01/2010EP2224016A1 Method for generating a circularised nucleic acid
09/01/2010EP2224010A1 Improved gene expression
09/01/2010EP2224009A1 Synthesis of sialic acid in plants
09/01/2010EP2224008A2 Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
09/01/2010EP2224007A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof
09/01/2010EP2224006A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
09/01/2010EP2224005A1 RNAi inhibition of alpha-ENaC expression
09/01/2010EP2224004A1 RNAi inhibition of alpha-ENaC expression
09/01/2010EP2224003A2 MicroRNA molecules
09/01/2010EP2224002A1 Np1 activity regulating elements which can be used in the production of drugs for the treatment or prevention of human neurodegenerative diseases, resulting drugs and use thereof
09/01/2010EP2224001A1 Improved epitope displaying phage
09/01/2010EP2224000A1 Antibody and use thereof
09/01/2010EP2223999A1 Epha4 polypeptide having novel activity and use thereof
09/01/2010EP2223997A1 Method for producing multiple modifications in the chromosome of gram-negative bacteria and salmonella strains which are deficient in c-di-gmp synthesis obtained by said method
09/01/2010EP2223996A1 Transformant transfected with flavin adenine dinucleotide-binding glucose dehydrogenase gene and method for producing flavin adenine dinucleotide-binding glucose dehydrogenase using the same
09/01/2010EP2223939A1 Transgenic mice used as models for human pathologies originating from stem cells
09/01/2010EP2223938A1 Derivatives of exendin
09/01/2010EP2223935A2 Compounds and methods for treatment and diagnosis of chlamydial infection
09/01/2010EP2223933A1 Genes encoding major capsid protein l1 of human papilloma viruses
09/01/2010EP2223932A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
09/01/2010EP2223931A1 Novel nucleic acid base pair
09/01/2010EP2223695A1 RNAi inhibition of alpha-ENaC expression
09/01/2010EP2223694A1 RNAi inhibition of alpha-ENaC expression
09/01/2010EP2223693A1 RNAi inhibition of alpha-ENaC expression
09/01/2010EP2223692A1 RNAi inhibition of alpha-ENaC expression
09/01/2010EP2222861A2 Polypurine tract modified retroviral vectors
09/01/2010EP2222859A2 Trichome specific promoters
09/01/2010EP2222858A2 Down-regulation of gene expression using artificial micrornas
09/01/2010EP2222857A2 Plants with increased yield and/or increased tolerance to environmental stress (iy-bm)
09/01/2010EP2222856A2 Promoters from brassica napus for seed specific gene expression
09/01/2010EP2222855A1 Plants with modified starch metabolism
09/01/2010EP2222854A1 Dicarboxylic acid production in a filamentous fungus
09/01/2010EP2222853A1 Polysaccharide synthases (h)
09/01/2010EP2222850A1 Elimination of contaminants associated with nucleic acid amplification